USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
SOURCE PRODUCTION AND EQUIPMENT COMPANY
Address:
113 TEAL ST
ST. ROSE, LA 70087
Phone:
N/A
URL:
N/A
EIN:
172074929
DUNS:
69542181
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $306,801.00 3
SBIR Phase II $750,394.00 1

Award List:

Brachytherapy Delivery System for Treatment of Lung Cancer

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Phase I program intends to develop an improved brachytherapy delivery system for treatment of lung cancer by incorporating radioactive 169Ytterbium sources into surgical staples used in lung resection. For patients with compromised cardiopulmonary status,… More

Brachytherapy Delivery System for Treatment of Lung Cancer

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$750,394.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Phase II program intends to continue to develop an improved brachytherapy delivery system for treatment of lung cancer by incorporating radioactive 169Ytterbium sources into surgical staples used in lung resect ion. For patients with compromised… More

Intensity Modulated Breast Brachytherapy System

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The overall objective of this Phase I program is to demonstrate the feasibility of delivering intensity modulated breast brachytherapy, permitting balloon-based breast brachytherapy to better conform to patient anatomy, reduce potential toxicity by reducing skin… More

HDR Brachytherapy for Intraocular Melanoma

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$106,801.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): HDR Brachytherapy for Intraocular Melanoma - Project Summary/Abstract The overall objective of this Phase I program is to develop a brachytherapy system for the treatment of intraocular melanoma that reduces hospitaliza tion time, provides improved dosimetry to… More